BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913-930. [PMID: 11442521 DOI: 10.1046/j.0007-1323.2001.01800.x] [Cited by in Crossref: 444] [Cited by in F6Publishing: 330] [Article Influence: 22.2] [Reference Citation Analysis]
Number Citing Articles
1 Hashimoto D, Nakagawa S, Umezaki N, Yamao T, Kitano Y, Yamamura K, Kaida T, Arima K, Imai K, Yamashita YI, Chikamoto A, Baba H. Efficacy and safety of postoperative anticoagulation prophylaxis with enoxaparin in patients undergoing pancreatic surgery: A prospective trial and literature review. Pancreatology. 2017;17:464-470. [PMID: 28366422 DOI: 10.1016/j.pan.2017.03.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Baltatzis M, Low R, Stathakis P, Sheen AJ, Siriwardena AK, Jamdar S. Efficacy and safety of pharmacological venous thromboembolism prophylaxis following liver resection: a systematic review and meta-analysis. HPB (Oxford) 2017;19:289-96. [PMID: 28162922 DOI: 10.1016/j.hpb.2017.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Zwischenberger BA, Tzeng CD, Ward ND, Zwischenberger JB, Martin JT. Venous Thromboembolism Prophylaxis For Esophagectomy: A Survey of Practice Patterns Among Thoracic Surgeons. The Annals of Thoracic Surgery 2016;101:489-94. [DOI: 10.1016/j.athoracsur.2015.07.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
4 Kirwan CC, Mccollum CN, Bundred NJ, Byrne GJ. Current UK practice of thromboprophylaxis for breast surgery. British Journal of Surgery 2006;93:1224-5. [DOI: 10.1002/bjs.5495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, Kahn SR, Rahman M, Rajasekhar A, Rogers FB, Smythe MA, Tikkinen KAO, Yates AJ, Baldeh T, Balduzzi S, Brożek JL, Ikobaltzeta IE, Johal H, Neumann I, Wiercioch W, Yepes-Nuñez JJ, Schünemann HJ, Dahm P. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 2019;3:3898-944. [PMID: 31794602 DOI: 10.1182/bloodadvances.2019000975] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 95.0] [Reference Citation Analysis]
6 Wang Y, Huang D, Wang M, Liang Z. Can Intermittent Pneumatic Compression Reduce the Incidence of Venous Thrombosis in Critically Ill Patients: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost 2020;26:1076029620913942. [PMID: 33074726 DOI: 10.1177/1076029620913942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, Mariani E, Flamini O, Pucciarelli S, Donini A, Agnelli G. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259:665-669. [PMID: 24253138 DOI: 10.1097/sla.0000000000000340] [Cited by in Crossref: 98] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
8 Krell RW, Scally CP, Wong SL, Abdelsattar ZM, Birkmeyer NJ, Fegan K, Todd J, Henke PK, Campbell DA, Hendren S. Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery. Ann Surg Oncol 2016;23:1431-9. [PMID: 26567148 DOI: 10.1245/s10434-015-4970-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mahan CE, Borrego ME, Woersching AL, Federici R, Downey R, Tiongson J, Bieniarz MC, Cavanaugh BJ, Spyropoulos AC. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost 2012;108:291-302. [PMID: 22739656 DOI: 10.1160/TH12-03-0162] [Cited by in Crossref: 94] [Cited by in F6Publishing: 27] [Article Influence: 10.4] [Reference Citation Analysis]
10 Adiguzel C, Iqbal O, Hoppensteadt D, Jeske W, Cunanan J, Litinas E, He Zhu, Walenga JM, Fareed J. Comparative Anticoagulant and Platelet Modulatory Effects of Enoxaparin and Sulodexide. Clin Appl Thromb Hemost 2009;15:501-11. [DOI: 10.1177/1076029609338711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Eikelboom JW. Effect of fondaparinux 2.5 mg once daily on mortality: a meta-analysis of phase III randomized trials of venous thromboembolism prevention. European Heart Journal Supplements 2008;10:C8-C13. [DOI: 10.1093/eurheartj/sun004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
12 Elder S, Hobson DB, Rand CS, Streiff MB, Haut ER, Efird LE, Kraus PS, Lehmann CU, Shermock KM. Hidden Barriers to Delivery of Pharmacological Venous Thromboembolism Prophylaxis: The Role of Nursing Beliefs and Practices. Journal of Patient Safety 2016;12:63-8. [DOI: 10.1097/pts.0000000000000086] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 4.6] [Reference Citation Analysis]
13 Lee AY. The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients: . Current Opinion in Pulmonary Medicine 2003;9:351-5. [DOI: 10.1097/00063198-200309000-00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
14 Rausa E, Kelly ME, Asti E, Aiolfi A, Bonitta G, Winter DC, Bonavina L. Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials. Surgery 2018;164:1234-40. [PMID: 30190110 DOI: 10.1016/j.surg.2018.05.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
15 Grobben RB, van Waes JAR, Leiner T, Peelen LM, de Borst GJ, Vogely HC, Grobbee DE, Doevendans PA, van Klei WA, Nathoe HM. Unexpected Cardiac Computed Tomography Findings in Patients With Postoperative Myocardial Injury: . Anesthesia & Analgesia 2018;126:1462-8. [DOI: 10.1213/ane.0000000000002580] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
16 Saraiya B, Goodin S. Management of venous thromboembolism and the potential to impact overall survival in patients with cancer. Pharmacotherapy 2009;29:1344-56. [PMID: 19857150 DOI: 10.1592/phco.29.11.1344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Levin PD, Weissman C. Obesity, metabolic syndrome, and the surgical patient. Med Clin North Am 2009;93:1049-63. [PMID: 19665619 DOI: 10.1016/j.mcna.2009.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
18 Clarke-pearson DL, Barber EL. Venous thromboembolism in gynecologic surgery: Are we any closer to determining an optimal prophylaxis regimen? Gynecologic Oncology 2015;138:495-6. [DOI: 10.1016/j.ygyno.2015.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
19 Falciani M, Imberti D, Prisco D. Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update. Intern Emerg Med 2006;1:273-8. [PMID: 17217148 DOI: 10.1007/BF02934760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
20 Jeong O, Ryu SY, Park YK, Kim YJ. The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery. Ann Surg Oncol 2010;17:2363-9. [PMID: 20358302 DOI: 10.1245/s10434-010-1032-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
21 Giustozzi M, Franco L, Vedovati MC, Becattini C, Agnelli G. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism. J Thromb Thrombolysis 2019;48:439-53. [DOI: 10.1007/s11239-019-01878-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Wasowicz-kemps DK, Biesma DH, Schagen Van Leeuwen J, Van Ramshorst B. Prophylaxis of venous thromboembolism in general and gynecologic day surgery in the Netherlands: Letters to the Editor. Journal of Thrombosis and Haemostasis 2006;4:269-71. [DOI: 10.1111/j.1538-7836.2005.01673.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
23 Working Group for Audit about Perioperative Accident and Pulmonary Embolism of Japanese Society of Anesthesiologists. Perioperative risk factors for death among patients with symptomatic pulmonary thromboembolism. J Anesth 2017;31:478-82. [PMID: 28280942 DOI: 10.1007/s00540-017-2324-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Berry C, Tcherniantchouk O, Ley EJ, Salim A, Mirocha J, Martin-stone S, Stolpner D, Margulies DR. Overdiagnosis of Heparin-Induced Thrombocytopenia in Surgical ICU Patients. Journal of the American College of Surgeons 2011;213:10-7. [DOI: 10.1016/j.jamcollsurg.2011.04.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
25 Benoist S, Brouquet A. Nutritional assessment and screening for malnutrition. Journal of Visceral Surgery 2015;152:S3-7. [DOI: 10.1016/s1878-7886(15)30003-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
26 Samama MM, Gerotziafas GT. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux). Thromb Res 2003;109:1-11. [PMID: 12679126 DOI: 10.1016/s0049-3848(03)00030-6] [Cited by in Crossref: 113] [Cited by in F6Publishing: 14] [Article Influence: 6.6] [Reference Citation Analysis]
27 Kakkar AK. Prevention of Venous Thromboembolism in the Cancer Surgical Patient. JCO 2009;27:4881-4. [DOI: 10.1200/jco.2009.23.2009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
28 Maclellan DG, Richardson A, Stoodley MA. Venous thromboembolism and cancer: Venous thromboembolism and cancer. ANZ Journal of Surgery 2012;82:294-8. [DOI: 10.1111/j.1445-2197.2012.06047.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J, Ageno W, Ajauro F, Al-aboudi KR, Alcindor T, Andre T, Angchaisuksiri P, Antic D, Arcelus JI, Assenat E, Bauer KA, Bazarbachii A, Benzidia I, Beyer-westendorf J, Bitsadze V, Blickstein D, Blostein M, Bogalho I, Bournet B, Casais P, Carpentier AF, Cesarman-maus G, Chakbrabartty J, Clemente H, Connault J, Doucet L, Durant C, Emmerich J, Falanga A, Feistritzer C, Font C, Francis C, Gallardo E, Gary T, Gris J, Guillermo C, Hij A, Hull RD, Ikezoe T, Jara-palomares L, Key NS, Khrizroeva J, Koolian M, Langer F, Le Hello C, Lecumberri R, Lee LH, Liebman H, Lopes Dos Santos L, Machado DH, Madelaine I, Makatsariya A, Mandala M, Marayevas A, Marjanovic Z, Marosi C, Martin E, Meillon L, Messas E, Moreira A, Demir AM, Ndour A, Nguessan M, Otero-candelera R, Pachon Olmos V, Pais A, Posch F, Preusser M, Riess H, Righini M, Rothschild C, Roussin A, Rueda-camino JA, Ruiz-artacho P, Saseedharan S, Shamseddine A, Soff G, Stricker H, Tagalakis V, Taher A, Toussaint T, Trujillo-santos J, Villiers S, Wong R, Yamada N. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. The Lancet Oncology 2019;20:e566-81. [DOI: 10.1016/s1470-2045(19)30336-5] [Cited by in Crossref: 169] [Cited by in F6Publishing: 59] [Article Influence: 84.5] [Reference Citation Analysis]
30 Hansrani V, Khanbhai M, McCollum C. The Prevention of Venous Thromboembolism in Surgical Patients. Adv Exp Med Biol 2017;906:1-8. [PMID: 27620304 DOI: 10.1007/5584_2016_100] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
31 Korte W. Cancer and thrombosis: an increasingly important association. Support Care Cancer 2008;16:223-8. [DOI: 10.1007/s00520-007-0376-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
32 Bergqvist D. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol 2007;95:167-74. [PMID: 17262765 DOI: 10.1002/jso.20625] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
33 Hein L. Antithrombotika und Antihämorrhagika. In: Schwabe U, Paffrath D, editors. Arzneiverordnungs-Report 2011. Berlin: Springer Berlin Heidelberg; 2011. pp. 421-39. [DOI: 10.1007/978-3-642-21992-4_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Aboagye JK, Haut ER, Streiff MB, Hobson DB, Kraus PS, Shaffer DL, Holzmueller CG, Lau BD. Audit and Feedback to Surgery Interns and Residents on Prescribing Risk-Appropriate Venous Thromboembolism Prophylaxis. J Surg Educ 2021:S1931-7204(21)00070-2. [PMID: 33879395 DOI: 10.1016/j.jsurg.2021.03.017] [Reference Citation Analysis]
35 Bagot C, Gohil S, Perrott R, Barsam S, Patel RK, Arya R. The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patients. QJM 2010;103:597-605. [DOI: 10.1093/qjmed/hcq100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
36 Chen SY, Molena D, Stem M, Mungo B, Lidor AO. Post-discharge complications after esophagectomy account for high readmission rates. World J Gastroenterol 2016;22:5246-53. [PMID: 27298567 DOI: 10.3748/wjg.v22.i22.5246] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
37 Fareed J, Adiguzel C, Thethi I. Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism. Thromb J 2011;9:5. [PMID: 21443789 DOI: 10.1186/1477-9560-9-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Kwon S, Meissner M, Symons R, Steele S, Thirlby R, Billingham R, Flum DR; Surgical Care and Outcomes Assessment Program Collaborative. Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg 2011;213:596-603, 603.e1. [PMID: 21871823 DOI: 10.1016/j.jamcollsurg.2011.07.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
39 Laryea J, Champagne B. Venous thromboembolism prophylaxis.Clin Colon Rectal Surg. 2013;26:153-159. [PMID: 24436666 DOI: 10.1055/S-0033-135113] [Reference Citation Analysis]
40 Wołkowski K, Wołkowski M, Urbanek T. Venous Thromboembolism Prophylaxis and Thrombotic Risk Stratification in the Varicose Veins Surgery-Prospective Observational Study. J Clin Med 2020;9:E3970. [PMID: 33297575 DOI: 10.3390/jcm9123970] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Farray D, Carman TL, Fernandez BB. The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases. Neurologic Clinics 2004;22:423-39. [DOI: 10.1016/j.ncl.2004.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
42 Kligman MD, Zyromski NJ, McCullough DG, Gunning WT. Platelet-dense granule deficiency causes postoperative hemorrhage in patients receiving enoxaparin: a novel observation with dramatic clinical implications. Am J Surg 2009;197:365-70. [PMID: 19245916 DOI: 10.1016/j.amjsurg.2008.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Fleming F, Gaertner W, Ternent CA, Finlayson E, Herzig D, Paquette IM, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery. Dis Colon Rectum. 2018;61:14-20. [PMID: 29219916 DOI: 10.1097/dcr.0000000000000982] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 12.7] [Reference Citation Analysis]
44 Kurmis AP. Review article: thromboprophylaxis after total hip replacement. J Orthop Surg (Hong Kong) 2010;18:92-7. [PMID: 20427844 DOI: 10.1177/230949901001800121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Niccolai CS, Hicks RW, Oertel L, Francis JL; Heparin Consensus Group. Unfractionated heparin: focus on a high-alert drug. Pharmacotherapy 2004;24:146S-55S. [PMID: 15334861 DOI: 10.1592/phco.24.12.146s.36107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
46 Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA, Pabinger I, Solymoss S, Douketis J, Kakkar A. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2016;17:e452-e466. [PMID: 27733271 DOI: 10.1016/s1470-2045(16)30369-2] [Cited by in Crossref: 218] [Cited by in F6Publishing: 83] [Article Influence: 54.5] [Reference Citation Analysis]
47 Al-Hameed FM, Al-Dorzi HM, Abdelaal MA, Alaklabi A, Bakhsh E, Alomi YA, Al Baik M, Aldahan S, Schünemann H, Brozek J, Wiercioch W, Darzi AJ, Waziry R, Akl EA. The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients. Saudi Med J 2016;37:1279-93. [PMID: 27761572 DOI: 10.15537/smj.2016.11.15268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
48 Schleyer AM, Schreuder AB, Jarman KM, Logerfo JP, Goss JR. Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United States. Am J Med Qual 2011;26:174-80. [PMID: 21490270 DOI: 10.1177/1062860610382289] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
49 Varpe P, Huhtinen H, Rantala A, Grönroos J. Thromboprophylaxis following Surgery for Colorectal Cancer — Is it Worthwhile after Hospital Discharge? Scand J Surg 2009;98:58-61. [DOI: 10.1177/145749690909800111] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
50 Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller PG, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K, Othman M, Gresele P. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Haematologica 2020;105:1948-56. [PMID: 31558677 DOI: 10.3324/haematol.2019.227876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Barber EL, Clarke-Pearson DL. The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients. Am J Obstet Gynecol 2016;215:445.e1-9. [PMID: 27131583 DOI: 10.1016/j.ajog.2016.04.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
52 Liu DS, Stevens S, Wong E, Fong J, Mori K, Ward S, Lee S, Howard T, Jain A, Gill AS, Beh PS, Slevin M, Jamel W, Fleming N, Bennet S, Chung C, Crowe A, Muralidharan V; the VERITAS Collaborative. Pre‐operative and intra‐operative chemical thromboprophylaxis increases bleeding risk following elective cholecystectomy: a multicentre ( PROTECTinG ) study. ANZ Journal of Surgery 2020;90:2449-55. [DOI: 10.1111/ans.15998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Javanainen MH, Scheinin T, Mustonen H, Leivonen M. Retrospective analysis of 3 different antithrombotic prophylaxis regimens in bariatric surgery. Surgery for Obesity and Related Diseases 2016;12:675-80. [DOI: 10.1016/j.soard.2015.12.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
54 Yue BYT, Zinn R, Roberts R, Wilson J. Use of thrombin-based haemostatic matrix in head and neck reconstructions: a potential risk factor for pulmonary embolism: Haemostatic matrix and pulmonary embolism. ANZ J Surg 2017;87:E276-80. [DOI: 10.1111/ans.13618] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
55 Guo Q, Huang B, Zhao J, Ma Y, Yuan D, Yang Y, Du X. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis. Annals of Surgery 2017;265:1087-93. [DOI: 10.1097/sla.0000000000002074] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
56 Sakon M, Maehara Y, Kobayashi T, Kobayashi H, Shimazui T, Seo N, Crawford B, Miyoshi I. Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery. Value Health Reg Issues 2015;6:73-9. [PMID: 29698197 DOI: 10.1016/j.vhri.2015.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Motte S, Samama CM, Guay J, Barrê J, Borg J, Rosencher N. Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis. Can J Anesth/J Can Anesth 2006;53:S68-79. [DOI: 10.1007/bf03022254] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
58 White RH, Ginsberg JS. Low-Molecular-Weight Heparins: Are they all the Same?: Review. British Journal of Haematology 2003;121:12-20. [DOI: 10.1046/j.1365-2141.2003.04196.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
59 Pannucci CJ, Wachtman CF, Dreszer G, Bailey SH, Portschy PR, Hamill JB, Hume KM, Hoxworth RE, Kalliainen LK, Rubin JP, Pusic AL, Wilkins EG. The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg 2012;129:160-8. [PMID: 21915085 DOI: 10.1097/PRS.0b013e318236215c] [Cited by in Crossref: 70] [Cited by in F6Publishing: 7] [Article Influence: 7.8] [Reference Citation Analysis]
60 Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A. Venous thromboembolic disease. J Natl Compr Canc Netw 2011;9:714-77. [PMID: 21715723 DOI: 10.6004/jnccn.2011.0062] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
61 Reyhan E, İrkörücü O, Sürmelioğlu A, Özkara S, Değer KC, Aziret M, Erdem H, Çetinkünar S, Tilki M, Demirtürk P, Akpinar E. Abolition of anti-adhesiogenic effect of heparin by protamine sulfate. International Journal of Surgery 2014;12:729-33. [DOI: 10.1016/j.ijsu.2014.05.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
62 Gidiri M, Sant M, Philips K, Lindow S. Thromboprophylaxis for caesarean section—how can uptake and coverage be improved? Journal of Obstetrics and Gynaecology 2009;24:392-4. [DOI: 10.1080/01443610410001685510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Yu R, Nansubuga F, Yang J, Ding W, Li K, Weng D, Wu P, Chen G, Ma D, Wei J. Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery. Medicine 2020;99:e20928. [DOI: 10.1097/md.0000000000020928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Otero Candelera R, Grau Segura E, Jiménez Castro D, Uresandi Romero F, López Villalobos JL, Calderón Sandubete E, Medrano Ortega FJ, Cayuela Domínguez A. Profilaxis de la enfermedad tromboembólica venosa. Archivos de Bronconeumología 2008;44:160-9. [DOI: 10.1157/13116604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
65 Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S-400S. [PMID: 15383478 DOI: 10.1378/chest.126.3_suppl.338s] [Cited by in Crossref: 2089] [Cited by in F6Publishing: 311] [Article Influence: 122.9] [Reference Citation Analysis]
66 Polk HC, Mccafferty MH, Mahid SS, Naidu DK, Lewis JN. Attitudes of Surgical Specialists toward Venous Thromboembolism Prophylaxis in Surgical Patients. The American Surgeon 2008;74:189-94. [DOI: 10.1177/000313480807400301] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
67 Song KY, Yoo HM, Kim EY, Kim J, Yim HW, Jeon HM, Park CH. Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients: An Interim Analysis of Prospective Randomized Trial. Ann Surg Oncol 2014;21:4232-8. [DOI: 10.1245/s10434-014-3893-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
68 Beyer J, Wessela S, Hakenberg OW, Kuhlisch E, Halbritter K, Froehner M, Wirth MP, Schellong SM. Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery. Journal of Thrombosis and Haemostasis 2009;7:597-604. [DOI: 10.1111/j.1538-7836.2009.03275.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
69 Jaffer AK, Brotman DJ. Prevention of venous thromboembolism after surgery. Clin Geriatr Med 2008;24:625-39, viii. [PMID: 18984377 DOI: 10.1016/j.cger.2008.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 García Botero A, García Wenninger M, Fernández Loaiza D. Complications After Body Contouring Surgery in Postbariatric Patients. Annals of Plastic Surgery 2017;79:293-7. [DOI: 10.1097/sap.0000000000001109] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
71 Dorudi S, Steele RJ, McArdle CS. Surgery for colorectal cancer. Br Med Bull 2002;64:101-18. [PMID: 12421728 DOI: 10.1093/bmb/64.1.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
72 Levi M, Eerenberg E, Kamphuisen PW. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. J Thromb Haemost. 2011;9:1705-1712. [PMID: 21729240 DOI: 10.1111/j.1538-7836.2011.04432.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 77] [Article Influence: 12.0] [Reference Citation Analysis]
73 Fong ZV, Sell NM, Fernandez-Del Castillo C, Del Carmen G, Ferrone CR, Chang DC, Warshaw AL, Polk HC Jr, Lillemoe KD, Qadan M. Does preoperative pharmacologic prophylaxis reduce the rate of venous thromboembolism in pancreatectomy patients? HPB (Oxford). 2020;22:1020-1024. [PMID: 31732463 DOI: 10.1016/j.hpb.2019.10.2437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Cevik J, Middleton R, Ramakrishnan A, Cabalag M. Rationalizing post-operative prophylactic anticoagulation in reconstructive head and neck cancer patients: a review. ANZ J Surg 2021. [PMID: 33724659 DOI: 10.1111/ans.16742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kyrle PA, Eichinger S. Deep vein thrombosis. The Lancet 2005;365:1163-74. [DOI: 10.1016/s0140-6736(05)71880-8] [Cited by in Crossref: 319] [Cited by in F6Publishing: 58] [Article Influence: 19.9] [Reference Citation Analysis]
76 Martinez L, Burnett A, Borrego M, Streeter JC, Townsend K, Garcia D. Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity. Am J Health Syst Pharm 2011;68:1716-22. [PMID: 21880887 DOI: 10.2146/ajhp110010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
77 Frere C, Farge D. Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients. Thromb Haemost 2017;116:618-25. [DOI: 10.1160/th16-04-0302] [Cited by in Crossref: 16] [Article Influence: 4.0] [Reference Citation Analysis]
78 Felder S, Rasmussen MS, King R, Sklow B, Kwaan M, Madoff R, Jensen C. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2019;8:CD004318. [PMID: 31449321 DOI: 10.1002/14651858.cd004318.pub5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
79 Shermak MA, Chang DC, Heller J. Factors impacting thromboembolism after bariatric body contouring surgery. Plast Reconstr Surg 2007;119:1590-6. [PMID: 17415254 DOI: 10.1097/01.prs.0000256070.37066.7e] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
80 Barber EL, Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol 2017;144:420-7. [PMID: 27890280 DOI: 10.1016/j.ygyno.2016.11.036] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
81 Brummer THI, Heikkinen A, Jalkanen J, Fraser J, Makinen J, Tomas E, Seppala T, Sjoberg J, Harkki P. Pharmaceutical thrombosis prophylaxis, bleeding complications and thromboembolism in a national cohort of hysterectomy for benign disease. Human Reproduction 2012;27:1628-36. [DOI: 10.1093/humrep/des103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
82 Magaña M, Bercovitch R, Fedullo P. Diagnostic approach to deep venous thrombosis and pulmonary embolism in the critical care setting. Crit Care Clin 2011;27:841-67, vi. [PMID: 22082517 DOI: 10.1016/j.ccc.2011.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
83 Er O, Zacharski L. Management of cancer-associated venous thrombosis. Vasc Health Risk Manag 2006;2:351-6. [PMID: 17323588 DOI: 10.2147/vhrm.2006.2.4.351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
84 Laryea J, Champagne B. Venous thromboembolism prophylaxis. Clin Colon Rectal Surg 2013;26:153-9. [PMID: 24436666 DOI: 10.1055/s-0033-1351130] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
85 Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e691S-e736S. [PMID: 22315276 DOI: 10.1378/chest.11-2300] [Cited by in Crossref: 845] [Cited by in F6Publishing: 541] [Article Influence: 93.9] [Reference Citation Analysis]
86 Cunningham M, White B, O'donnell J. Prevention and Management of Venous Thromboembolism in People with Cancer: A Review of the Evidence. Clinical Oncology 2006;18:145-51. [DOI: 10.1016/j.clon.2005.10.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
87 Samama C, Boubli L, Coloby P, Debourdeau P, Gruel Y, Mariette C, Mottier D, Rischmann P, Toubiana L, Steib A. Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer – A real-world, prospective, observational French study: PRéOBS. Thrombosis Research 2014;133:985-92. [DOI: 10.1016/j.thromres.2013.10.038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
88 Friess H, Ho C, Kleeff J, Büchler M. Pancreaticoduodenectomy, Distal Pancreatectomy, Segmental Pancreatectomy, Total Pancreatectomy, and Transduodenal Resection of the Papilla of Vater. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 877-903. [DOI: 10.1016/b978-1-4160-3256-4.50068-5] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
89 Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 2013;15:773-80. [PMID: 23869577 DOI: 10.1111/hpb.12130] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
90 McNally MP, Burns CJ. Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg 2009;22:34-40. [PMID: 20119554 DOI: 10.1055/s-0029-1202884] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
91 Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford) 2014;16:373-83. [PMID: 23869628 DOI: 10.1111/hpb.12148] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
92 Agnelli G, Caprini JA. The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options. J Surg Oncol 2007;96:265-72. [DOI: 10.1002/jso.20808] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
93 Wong P, Baglin T. Epidemiology, risk factors and sequelae of venous thromboembolism. Phlebology 2012;27 Suppl 2:2-11. [PMID: 22457300 DOI: 10.1258/phleb.2012.012s31] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
94 Qiu M, Huang S, Luo C, Wu Z, Liang B, Huang H, Ci Z, Zhang D, Han L, Lin J. Pharmacological and clinical application of heparin progress: An essential drug for modern medicine. Biomed Pharmacother 2021;139:111561. [PMID: 33848775 DOI: 10.1016/j.biopha.2021.111561] [Reference Citation Analysis]
95 Piechowski KL, Elder S, Efird LE, Haut ER, Streiff MB, Lau BD, Kraus PS, Rand CS, Popoola VO, Hobson DB, Farrow NE, Shaffer D, Shermock KM. Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis. J Thromb Thrombolysis 2016;42:463-70. [PMID: 27209202 DOI: 10.1007/s11239-016-1378-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
96 Nishimori M, Low JH, Zheng H, Ballantyne JC. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2012;7:CD005059. [PMID: 22786494 DOI: 10.1002/14651858.cd005059.pub3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
97 Galante M, Languasco A, Gotta D, Bell S, Lancelotti T, Knaze V, Saubidet CL, Grand B, Milberg M. Venous thromboprophylaxis in general surgery ward admissions: strategies for improvement. Int J Qual Health Care 2012;24:649-56. [PMID: 22893664 DOI: 10.1093/intqhc/mzs052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
98 Stahl TJ, Gregorcyk SG, Hyman NH, Buie WD. Practice Parameters for the Prevention of Venous Thrombosis. Diseases of the Colon & Rectum 2006;49:1477-83. [DOI: 10.1007/s10350-006-0686-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
99 Liebman HA. Current Perspectives on Primary Prophylaxis and Patient Risk Factors for Venous Thromboembolism in the Cancer Patient. Cancer Control 2017;12:11-6. [DOI: 10.1177/1073274805012003s03] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
100 Okuhara A, Navarro TP, Procópio RJ, Bernardes Rde C, Oliveira Lde C, Nishiyama MP. Incidence of deep vein thrombosis and quality of venous thromboembolism prophylaxis. Rev Col Bras Cir 2014;41:2-6. [PMID: 24770766 DOI: 10.1590/s0100-69912014000100002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Hamad GG, Bergqvist D. Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surgery for Obesity and Related Diseases 2007;3:97-102. [DOI: 10.1016/j.soard.2006.10.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
102 Hoppensteadt DA, Kaiser B, Fareed J. Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders. Expert Opinion on Investigational Drugs 2005;10:1925-35. [DOI: 10.1517/13543784.10.11.1925] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
103 Roche-Nagle G, Curran J, Bouchier-Hayes DJ, Tierney S. Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily? Ir J Med Sci 2007;176:169-73. [PMID: 17554579 DOI: 10.1007/s11845-007-0049-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Doughtie CA, Priddy EE, Philips P, Martin RC, McMasters KM, Scoggins CR. Preoperative dosing of low-molecular-weight heparin in hepatopancreatobiliary surgery. Am J Surg. 2014;208:1009-15; discussion 1015. [PMID: 25435300 DOI: 10.1016/j.amjsurg.2014.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
105 Mukherjee D, Lidor AO, Chu KM, Gearhart SL, Haut ER, Chang DC. Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg. 2008;12:2015-2022. [PMID: 18668299 DOI: 10.1007/s11605-008-0600-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
106 Brown LB, Streiff MB, Haut ER. Venous Thromboembolism Prevention and Treatment in Cancer Surgery. Adv Surg 2020;54:17-30. [PMID: 32713428 DOI: 10.1016/j.yasu.2020.04.002] [Reference Citation Analysis]
107 Hata T, Yasui M, Murata K, Okuyama M, Ohue M, Ikeda M, Ueshima S, Kitani K, Hasegawa J, Tamagawa H, Fujii M, Ohkawa A, Kato T, Morita S, Fukuzaki T, Mizushima T, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO). Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study. Surg Today 2014;44:2116-23. [PMID: 24840400 DOI: 10.1007/s00595-014-0911-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
108 Autar R. NICE guidelines on reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing surgery. Journal of Orthopaedic Nursing 2007;11:169-76. [DOI: 10.1016/j.joon.2007.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
109 Parikh S, Jakeman B, Walsh E, Townsend K, Burnett A. Adjusted-Dose Enoxaparin for VTE Prevention in the Morbidly Obese. Journal of Pharmacy Technology 2015;31:282-8. [DOI: 10.1177/8755122515593381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Robert F. The potential benefits of low-molecular-weight heparins in cancer patients. J Hematol Oncol 2010;3:3. [PMID: 20074349 DOI: 10.1186/1756-8722-3-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
111 Lauk O, Hoda MA, de Perrot M, Friess M, Klikovits T, Klepetko W, Keshavjee S, Weder W, Opitz I. Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions. Ann Thorac Surg 2014;98:1748-54. [PMID: 25110339 DOI: 10.1016/j.athoracsur.2014.05.071] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
112 Linkins LA. Management of venous thromboembolism in patients with cancer: role of dalteparin. Vasc Health Risk Manag 2008;4:279-87. [PMID: 18561503 DOI: 10.2147/vhrm.s2132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
113 Chen Y, Zhao J, Zhang Z, Ding Z, Chen Y, Chen X, Zhang W. Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study. J Hepatocell Carcinoma 2021;8:783-94. [PMID: 34322456 DOI: 10.2147/JHC.S311970] [Reference Citation Analysis]
114 Wilson KC, Merli GJ. Performance measures for improving the prevention of venous thromboembolism: achievement in clinical practice. J Thromb Thrombolysis 2011;32:293-302. [PMID: 21667203 DOI: 10.1007/s11239-011-0605-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
115 Peng C, Doan J, Monagle P, Newall F. Compliance of antithrombotic management at a tertiary paediatric hospital with international guidelines: A 100-Day audit. Thrombosis Research 2011;128:135-40. [DOI: 10.1016/j.thromres.2011.03.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
116 Eikelboom JW, Hankey GJ. Low molecular weight heparins and heparinoids. Med J Aust 2002;177:379-83. [PMID: 12358583 DOI: 10.5694/j.1326-5377.2002.tb04807.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
117 Geerts W. Prevention of venous thromboembolism: a key patient safety priority. J Thromb Haemost 2009;7 Suppl 1:1-8. [PMID: 19630756 DOI: 10.1111/j.1538-7836.2009.03384.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
118 Lee AY. Cancer and venous thromboembolism: prevention, treatment and survival. J Thromb Thrombolysis 2008;25:33-6. [PMID: 17906917 DOI: 10.1007/s11239-007-0102-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
119 Fareed J, Jeske W, Fareed D, Clark M, Wahi R, Adiguzel C, Hoppensteadt D. Are all low molecular weight heparins equivalent in the management of venous thromboembolism? Clin Appl Thromb Hemost 2008;14:385-92. [PMID: 18815137 DOI: 10.1177/1076029608319881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
120 Brose KM, Lee AY. Cancer-associated thrombosis: prevention and treatment. Curr Oncol 2008;15:S58-67. [PMID: 18231650 DOI: 10.3747/co.2008.177] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
121 Scheres LJ, Bistervels IM, Middeldorp S. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy. Blood Reviews 2019;33:82-97. [DOI: 10.1016/j.blre.2018.08.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
122 Kimura Y, Oki E, Ando K, Saeki H, Kusumoto T, Maehara Y. Incidence of Venous Thromboembolism Following Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study. World J Surg. 2016;40:309-314. [PMID: 26316113 DOI: 10.1007/s00268-015-3234-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
123 Stashenko G, Lopes RD, Garcia D, Alexander JH, Tapson VF. Prophylaxis for venous thromboembolism: guidelines translated for the clinician. J Thromb Thrombolysis 2011;31:122-32. [PMID: 20936495 DOI: 10.1007/s11239-010-0522-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
124 Balibrea J, Altimiras J, Larruzea I, Gómez-outes A, Martínez-gonzález J, Rocha E. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: An audit of practice. International Journal of Surgery 2007;5:114-9. [DOI: 10.1016/j.ijsu.2006.07.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
125 Sevestre M, Labarere J, Brin S, Carpentier P, Constans J, Degeilh M, Deslandes B, Elgrishi I, Lanoye P, Laroche J, Le Roux P, Pichot O, Quéré I, Bosson J. Optimisation de l’interrogatoire dans l’évaluation du risque de maladie thromboembolique veineuse : l’étude OPTIMEV. Journal des Maladies Vasculaires 2005;30:217-27. [DOI: 10.1016/s0398-0499(05)88206-x] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
126 Mir MC, Zargar H, Bolton DM, Murphy DG, Lawrentschuk N. Enhanced Recovery After Surgery protocols for radical cystectomy surgery: review of current evidence and local protocols: Review of ERAS in radical cystectomy. ANZ J Surg 2015;85:514-20. [DOI: 10.1111/ans.13043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
127 Thabut G, Estellat C, Boutron I, Samama CM, Ravaud P. Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism. European Heart Journal 2006;27:227-36. [DOI: 10.1093/eurheartj/ehi587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
128 Al-Hameed FM, Al-Dorzi HM, Qadhi AI, Shaker A, Al-Gahtani FH, Al-Jassir FF, Zahir GF, Al-Khuwaitir TS, Addar MH, Al-Hajjaj MS, Abdelaal MA, Aboelnazar EY. Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia. Ann Thorac Med 2017;12:282-9. [PMID: 29118862 DOI: 10.4103/atm.ATM_101_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
129 Chen YW, Fong ZV, Qadan M, Kunitake H, Mullen JT, Chang DC. Should all patients receive the same prophylaxis? Racial variation in the risk of venous thromboembolism after major abdominal operations. Am J Surg 2021:S0002-9610(21)00331-7. [PMID: 34144805 DOI: 10.1016/j.amjsurg.2021.05.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Clements RH, Yellumahanthi K, Ballem N, Wesley M, Bland KI. Pharmacologic Prophylaxis Against Venous Thromboembolic Complications Is Not Mandatory for All Laparoscopic Roux-en-Y Gastric Bypass Procedures. Journal of the American College of Surgeons 2009;208:917-21. [DOI: 10.1016/j.jamcollsurg.2009.01.034] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
131 Grant PJ, Brotman DJ, Jaffer AK. Perioperative anticoagulant management. Med Clin North Am 2009;93:1105-21. [PMID: 19665623 DOI: 10.1016/j.mcna.2009.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
132 Burgess APH, Clark SL. Opportunities for hospitals, hospital systems and leadership to improve VTE prophylaxis. Semin Perinatol 2019;43:218-21. [PMID: 30979595 DOI: 10.1053/j.semperi.2019.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
133 Bergqvist D. Assessment of the Risk and the Prophylaxis of Venous Thromboembolism in Surgical Patients. Pathophysiol Haemos Thromb 2003;33:358-61. [DOI: 10.1159/000083829] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
134 Kamachi H, Homma S, Kawamura H, Yoshida T, Ohno Y, Ichikawa N, Yokota R, Funakoshi T, Maeda Y, Takahashi N, Amano T, Taketomi A. Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open 2020;4:804-10. [PMID: 32700415 DOI: 10.1002/bjs5.50323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N. Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol. 2015;13:204. [PMID: 26092573 DOI: 10.1186/s12957-015-0592-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
136 Pottecher J, Lefort H, Adam P, Barbier O, Bouzat P, Charbit J, Galinski M, Garrigue D, Gauss T, Georg Y, Hamada S, Harrois A, Kedzierewicz R, Pasquier P, Prunet B, Roger C, Tazarourte K, Travers S, Velly L, Gil-Jardiné C, Quintard H. Guidelines for the acute care of severe limb trauma patients. Anaesth Crit Care Pain Med 2021;40:100862. [PMID: 34059492 DOI: 10.1016/j.accpm.2021.100862] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
137 Nakagawa K, Watanabe J, Ota M, Suwa Y, Suzuki S, Suwa H, Momiyama M, Ishibe A, Saigusa Y, Yamanaka T, Kunisaki C, Endo I. Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404). Surg Today 2020;50:68-75. [DOI: 10.1007/s00595-019-01859-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
138 Zacharoulis D, Kakkar AK. Venous thromboembolism in laparoscopic surgery: . Current Opinion in Pulmonary Medicine 2003;9:356-61. [DOI: 10.1097/00063198-200309000-00003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
139 Frere C, Debourdeau P, Hij A, Cajfinger F, Onan MN, Panicot-dubois L, Dubois C, Farge D. Therapy for Cancer-Related Thromboembolism. Seminars in Oncology 2014;41:319-38. [DOI: 10.1053/j.seminoncol.2014.04.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
140 Emoto S, Nozawa H, Kawai K, Hata K, Tanaka T, Shuno Y, Nishikawa T, Sasaki K, Kaneko M, Hiyoshi M, Murono K, Ishihara S. Venous thromboembolism in colorectal surgery: Incidence, risk factors, and prophylaxis. Asian J Surg 2019;42:863-73. [PMID: 30683604 DOI: 10.1016/j.asjsur.2018.12.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
141 Torres C, Haut ER. Prevention, diagnosis, and management of venous thromboembolism in the critically ill surgical and trauma patient. Curr Opin Crit Care 2020;26:640-7. [PMID: 33027148 DOI: 10.1097/MCC.0000000000000771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
142 Kim JW, Chun EJ, Choi SI, Park DJ, Kim HH, Bang SM, Kim MJ, Lee JH, Lee MS, Lee JO, Kim YJ, Kim JH, Lee JS, Lee KW. A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients. PLoS One 2013;8:e61968. [PMID: 23613988 DOI: 10.1371/journal.pone.0061968] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
143 Jaffer AK, Brotman DJ. Prevention of Venous Thromboembolism in the Geriatric Patient. Clinics in Geriatric Medicine 2006;22:93-111. [DOI: 10.1016/j.cger.2005.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
144 Burbury K. Haemostatic challenges in the cancer patient: Focus on the perioperative period. Best Practice & Research Clinical Anaesthesiology 2013;27:493-511. [DOI: 10.1016/j.bpa.2013.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
145 Zareba P, Wu C, Agzarian J, Rodriguez D, Kearon C. Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery. British Journal of Surgery 2014;101:1053-62. [DOI: 10.1002/bjs.9527] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
146 Riha GM, Van PY, Differding JA, Schreiber MA; Oregon Health & Science University Trauma Research Group. Incidence of deep vein thrombosis is increased with 30 mg twice daily dosing of enoxaparin compared with 40 mg daily. Am J Surg 2012;203:598-602. [PMID: 22521049 DOI: 10.1016/j.amjsurg.2011.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
147 Mismetti P, Laporte S, Zufferey P, Epinat M, Decousus H, Cucherat M. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis: Vitamin K antagonists in orthopedic surgery. Journal of Thrombosis and Haemostasis 2004;2:1058-70. [DOI: 10.1111/j.1538-7836.2004.00757.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
148 Turley RS, Reddy SK, Shortell CK, Clary BM, Scarborough JE. Venous Thromboembolism After Hepatic Resection: Analysis of 5,706 Patients. J Gastrointest Surg 2012;16:1705-14. [DOI: 10.1007/s11605-012-1939-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
149 Dang JT, Szeto VG, Elnahas A, Ellsmere J, Okrainec A, Neville A, Malik S, Yorke E, Hong D, Biertho L, Jackson T, Karmali S. Canadian consensus statement: enhanced recovery after surgery in bariatric surgery. Surg Endosc 2020;34:1366-75. [PMID: 31209605 DOI: 10.1007/s00464-019-06911-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
150 Geahchan N, Basile M, Tohmeh M; DIONYS registry. Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Springerplus 2016;5:1541. [PMID: 27652114 DOI: 10.1186/s40064-016-3057-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
151 Cheung HY, Chung CC, Yau KK, Siu WT, Wong SK, Chiu E, Li MK. Risk of deep vein thrombosis following laparoscopic rectosigmoid cancer resection in chinese patients. Asian J Surg. 2008;31:63-68. [PMID: 18490217 DOI: 10.1016/s1015-9584(08)60060-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
152 Alexander M, Kirsa S, Wolfe R, MacManus M, Ball D, Solomon B, Burbury K. Thromboembolism in lung cancer - an area of urgent unmet need. Lung Cancer 2014;84:275-80. [PMID: 24679344 DOI: 10.1016/j.lungcan.2014.02.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
153 Kucher N, Spirk D, Kalka C, Mazzolai L, Nobel D, Banyai M, Frauchiger B, Bounameaux H. Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER). Journal of Thrombosis and Haemostasis 2008;6:2082-7. [DOI: 10.1111/j.1538-7836.2008.03172.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
154 Agnelli G, Verso M. Management of venous thromboembolism in patients with cancer: Management of VTE in cancer patients. Journal of Thrombosis and Haemostasis 2011;9:316-24. [DOI: 10.1111/j.1538-7836.2011.04346.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
155 Becattini C, Rondelli F, Vedovati MC, Camporese G, Giustozzi M, Boncompagni M, Pucciarelli S, Balzarotti R, Mariani E, Filippucci E, Donini A, Agnelli G. Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer. Haematologica 2015;100:e35-8. [PMID: 25216684 DOI: 10.3324/haematol.2014.109843] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
156 Franchini M, Montagnana M, Targher G, Manzato F, Lippi G. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. J Thromb Thrombolysis 2007;24:29-38. [PMID: 17396228 DOI: 10.1007/s11239-007-0028-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
157 Patiar S, Kirwan CC, Mcdowell G, Bundred NJ, Mccollum CN, Byrne GJ. Prevention of venous thromboembolism in surgical patients with breast cancer. British Journal of Surgery 2007;94:412-20. [DOI: 10.1002/bjs.5782] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
158 Frederiksen SG, Hedenbro JL, Norgren L. Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients. British Journal of Surgery 2003;90:547-8. [DOI: 10.1002/bjs.4068] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 4.3] [Reference Citation Analysis]
159 Riva N, Donadini MP, Ageno W. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation. Thromb Haemost 2017;113:1176-83. [DOI: 10.1160/th14-06-0563] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 14.3] [Reference Citation Analysis]
160 Losonczy H, Tar A. Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting. Orvosi Hetilap 2010;151:843-52. [DOI: 10.1556/oh.2010.28895] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
161 Fantony JJ, Gopalakrishna A, Noord MV, Inman BA. Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis. Eur Urol Focus 2016;2:189-96. [PMID: 28723534 DOI: 10.1016/j.euf.2015.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
162 Gulur P, Nishimori M, Ballantyne JC. Regional anaesthesia versus general anaesthesia, morbidity and mortality. Best Practice & Research Clinical Anaesthesiology 2006;20:249-63. [DOI: 10.1016/j.bpa.2005.10.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
163 Weng XS, Liu J, Wu D. Chinese Survey on Enhanced Recovery after Surgery and Thromboprophylaxis Following Arthroplasty. Orthop Surg 2020;12:900-6. [PMID: 32489003 DOI: 10.1111/os.12705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
164 Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009;28:465-76. [PMID: 19224134 DOI: 10.1007/s11239-009-0309-3] [Cited by in Crossref: 175] [Cited by in F6Publishing: 128] [Article Influence: 14.6] [Reference Citation Analysis]
165 Barker RC, Marval P. Venous thromboembolism: risks and prevention. Continuing Education in Anaesthesia Critical Care & Pain 2011;11:18-23. [DOI: 10.1093/bjaceaccp/mkq044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
166 Chowdhury S, Alrawaji F, Leenen LPH. Incidence and Nature of Lower-Limb Deep Vein Thrombosis in Patients with Polytrauma on Thromboprophylaxis: A Prospective Cohort Study. Vasc Health Risk Manag 2021;17:395-405. [PMID: 34262284 DOI: 10.2147/VHRM.S314951] [Reference Citation Analysis]
167 Otero Candelera R, Grau Segura E, Jiménez Castro D, Uresandi Romero F, López Villalobos JL, Calderón Sandubete E, Medrano Ortega FJ, Cayuela Domínguez A; Sociedad Española de Neumología y Cirugía Torácica. [Prophylaxis of venous thromboembolism]. Arch Bronconeumol 2008;44:160-9. [PMID: 18361888 DOI: 10.1016/s1579-2129(08)60031-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
168 Lynch AM, deLaforcade AM, Sharp CR. Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin. J Vet Emerg Crit Care (San Antonio) 2014;24:421-8. [PMID: 25154357 DOI: 10.1111/vec.12206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
169 Kuroda S, Kikuchi S, Kakiuchi Y, Watanabe M, Kuwada K, Tsumura T, Nishizaki M, Kagawa S, Hinotsu S, Fujiwara T. Efficacy and safety of short-term (3 days) enoxaparin in preventing venous thromboembolism after gastric cancer surgery: A single-center, prospective cohort study. Int J Surg 2021;89:105946. [PMID: 33892160 DOI: 10.1016/j.ijsu.2021.105946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Dar TI, Wani KA, Ashraf M, Malik A, Ahmad S, Gojwari TA, Iqbal A. Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience. Indian J Crit Care Med 2012;16:71-4. [PMID: 22988360 DOI: 10.4103/0972-5229.99107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
171 Bartlett MA, Mauck KF, Daniels PR. Prevention of venous thromboembolism in patients undergoing bariatric surgery. Vasc Health Risk Manag 2015;11:461-77. [PMID: 26316771 DOI: 10.2147/VHRM.S73799] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
172 Lee AY. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2005;128:291-302. [PMID: 15667530 DOI: 10.1111/j.1365-2141.2004.05292.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
173 Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of Venous Thromboembolism. Chest 2008;133:381S-453S. [DOI: 10.1378/chest.08-0656] [Cited by in Crossref: 2906] [Cited by in F6Publishing: 2077] [Article Influence: 223.5] [Reference Citation Analysis]
174 Lecumberri R, Feliu J, Rocha E. Tromboembolia venosa en pacientes con cáncer. Medicina Clínica 2006;127:22-32. [DOI: 10.1157/13089866] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
175 Kyrle PA. Predicting recurrent venous thromboembolism in cancer: is it possible? Thromb Res 2014;133 Suppl 2:S17-22. [PMID: 24862139 DOI: 10.1016/S0049-3848(14)50003-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
176 Khorana AA. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist 2007;12:1361-70. [PMID: 18055857 DOI: 10.1634/theoncologist.12-11-1361] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
177 ten Cate-hoek AJ, Prins MH. Low molecular weight heparins in cancer. Thrombosis Research 2008;122:584-98. [DOI: 10.1016/j.thromres.2006.12.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
178 Adams P, Riggio JM, Thomson L, Brandell-Marino R, Merli G. Clinical decision support systems to improve utilization of thromboprophylaxis: a review of the literature and experience with implementation of a computerized physician order entry program. Hosp Pract (1995). 2012;40:27-39. [PMID: 23086092 DOI: 10.3810/hp.2012.08.987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
179 Beitland S, Sandven I, Kjærvik L, Sandset PM, Sunde K, Eken T. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 2015;41:1209-19. [DOI: 10.1007/s00134-015-3840-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
180 Dolan S, Fitch M. The management of venous thromboembolism in cancer patients. British Journal of Nursing 2007;16:1308-12. [DOI: 10.12968/bjon.2007.16.21.27715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Coventry BJ, Bruening M, Whitfield R, Yong J. General Perioperative Complications. In: Coventry BJ, editor. General Surgery Risk Reduction. London: Springer; 2014. pp. 23-105. [DOI: 10.1007/978-1-4471-5391-7_2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Kucher N, Puck M, Blaser J, Bucklar G, Eschmann E, Lüscher TF. Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients. Journal of Thrombosis and Haemostasis 2009;7:1291-6. [DOI: 10.1111/j.1538-7836.2009.03509.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
183 Kotaska A. Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens. BJOG 2018;125:1109-16. [PMID: 29512316 DOI: 10.1111/1471-0528.15150] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
184 Teoh D, Berchuck A, Secord AA, Lee PS, Lowery WJ, Sfakianos GP, Valea FA, Myers ER, Havrilesky LJ. Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. Gynecologic Oncology 2011;122:467-72. [DOI: 10.1016/j.ygyno.2011.06.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
185 Keshava HB, Boffa DJ. Cardiovascular Complications Following Thoracic Surgery. Thoracic Surgery Clinics 2015;25:371-92. [DOI: 10.1016/j.thorsurg.2015.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
186 Laws A, Anderson K, Hu J, McLean K, Novak L, Dominici LS, Nakhlis F, Carty M, Caterson S, Chun Y, Duggan M, Barry W, Connell N, Golshan M, King TA. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Ann Surg Oncol 2018;25:3548-55. [PMID: 30128903 DOI: 10.1245/s10434-018-6696-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
187 Schellong SM, Encke A, Weber A, Bramlage P, Paar WD, Haas S. Benefits and Risks of Preventing Thromboembolism With Enoxaparin in Patients With General Surgery in Real World—The CLEVER Study. Clin Appl Thromb Hemost 2013;19:282-8. [DOI: 10.1177/1076029612461067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
188 Ruitenbeek K, Hugenholtz GCG, Adelmeijer J, Pereboom ITA, Meijers JCM, van der Bij W, Porte RJ, Erasmus ME, Lisman T. Development of a Hypercoagulable Status in Patients Undergoing Off-Pump Lung Transplantation despite Prolonged Conventional Coagulation Tests. Am J Respir Crit Care Med 2015;191:230-3. [DOI: 10.1164/rccm.201407-1228le] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
189 Kotaska A. Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines. Thromb J 2018;16:25. [PMID: 30337840 DOI: 10.1186/s12959-018-0180-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
190 Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ. Chest 2009;135:513-20. [DOI: 10.1378/chest.08-2655] [Cited by in Crossref: 141] [Cited by in F6Publishing: 109] [Article Influence: 11.8] [Reference Citation Analysis]
191 Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol 2007;14:929-36. [PMID: 17103259 DOI: 10.1245/s10434-006-9183-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
192 Borris LC. Barriers to the optimal use of anticoagulants after orthopaedic surgery. Arch Orthop Trauma Surg 2009;129:1441-5. [DOI: 10.1007/s00402-008-0765-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
193 Reddy SK, Turley RS, Barbas AS, Steel JL, Tsung A, Marsh JW, Clary BM, Geller DA. Post-Operative Pharmacologic Thromboprophylaxis after Major Hepatectomy: Does Peripheral Venous Thromboembolism Prevention Outweigh Bleeding Risks? J Gastrointest Surg 2011;15:1602-10. [DOI: 10.1007/s11605-011-1591-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
194 Pavic M, Debourdeau P, Aletti M, Farge-Bancel D, Rousset H. [Venous thromboembolism and cancer]. Rev Med Interne 2006;27:313-22. [PMID: 16414153 DOI: 10.1016/j.revmed.2005.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
195 Wright JD, Chen L, Jorge S, Burke WM, Tergas AI, Hou JY, Hu JC, Neugut AI, Ananth CV, Hershman DL. Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery. Gynecol Oncol 2016;141:531-7. [PMID: 27032377 DOI: 10.1016/j.ygyno.2016.03.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
196 Vandy FC, Wakefield TW. Thrombosis and Hemostasis. Comprehensive Vascular and Endovascular Surgery. Elsevier; 2009. pp. 21-38. [DOI: 10.1016/b978-0-323-05726-4.00003-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
197 Hope WW, Demeter BL, Newcomb WL, Schmelzer TM, Schiffern LM, Heniford BT, Sing RF. Postoperative pulmonary embolism: timing, diagnosis, treatment, and outcomes. The American Journal of Surgery 2007;194:814-9. [DOI: 10.1016/j.amjsurg.2007.08.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
198 Akl EA, Kahale LA, Sperati F, Neumann I, Labedi N, Terrenato I, Barba M, Sempos EV, Muti P, Cook D, Schünemann H; Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd009447.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
199 Zacharski LR, Loynes JT. The heparins and cancer: . Current Opinion in Pulmonary Medicine 2002;8:379-82. [DOI: 10.1097/00063198-200209000-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
200 Morris-Stiff G, White A, Gomez D, Toogood G, Lodge JP, Prasad KR. Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford). 2008;10:311-314. [PMID: 18982144 DOI: 10.1080/13651820802074431] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
201 Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg. 2005;92:1212-1220. [PMID: 16175516 DOI: 10.1002/bjs.5154] [Cited by in Crossref: 250] [Cited by in F6Publishing: 161] [Article Influence: 15.6] [Reference Citation Analysis]
202 Liu DS, Wong E, Fong J, Stevens S, Mori K; PROTECTinG Investigators, VERITAS Collaborative. Perioperative thromboprophylaxis is highly variable in general surgery: results from a multicentre survey. ANZ J Surg 2020;90:2401-3. [PMID: 33336486 DOI: 10.1111/ans.16223] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Yago H, Yamaki T, Sasaki Y, Homma K, Mizobuchi T, Hasegawa Y, Osada A, Sakurai H. Application of the Caprini Risk Assessment Model for Evaluating Postoperative Deep Vein Thrombosis in Patients Undergoing Plastic and Reconstructive Surgery. Ann Vasc Surg 2020;65:82-9. [PMID: 31678541 DOI: 10.1016/j.avsg.2019.10.082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
204 Blondon M. Thromboprophylaxis after cesarean section: decision analysis. Thrombosis Research 2011;127:S9-S12. [DOI: 10.1016/s0049-3848(11)70004-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
205 Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111:4902-4907. [PMID: 18216292 DOI: 10.1182/blood-2007-10-116327] [Cited by in Crossref: 1045] [Cited by in F6Publishing: 816] [Article Influence: 80.4] [Reference Citation Analysis]
206 Dixon E, Hameed M, Sutherland F, Cook DJ, Doig C. Evaluating meta-analyses in the general surgical literature: a critical appraisal. Ann Surg 2005;241:450-9. [PMID: 15729067 DOI: 10.1097/01.sla.0000154258.30305.df] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
207 Liu M, Wang G, Li Y, Wang H, Liu H, Guo N, Han C, Peng Y, Yang M, Liu Y, Ma X, Yu K, Wang C. Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis. Ther Adv Med Oncol 2020;12:1758835920907540. [PMID: 32215058 DOI: 10.1177/1758835920907540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
208 Ali NS, Nawaz A, Junaid M, Kazi M, Akhtar S. Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan. Int Arch Otorhinolaryngol 2015;19:200-4. [PMID: 26157492 DOI: 10.1055/s-0035-1549153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
209 Turpie AGG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE; ON BEHALF OF THE APOLLO INVESTIGATORS. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison: Fondaparinux and abdominal surgery. Journal of Thrombosis and Haemostasis 2007;5:1854-61. [DOI: 10.1111/j.1538-7836.2007.02657.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 73] [Article Influence: 7.6] [Reference Citation Analysis]
210 Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e227S-e277S. [PMID: 22315263 DOI: 10.1378/chest.11-2297] [Cited by in Crossref: 1185] [Cited by in F6Publishing: 838] [Article Influence: 131.7] [Reference Citation Analysis]
211 Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, Rustin G, Thomas M, Quigley M, Williamson RC. Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS). JCO 2004;22:1944-8. [DOI: 10.1200/jco.2004.10.002] [Cited by in Crossref: 470] [Cited by in F6Publishing: 113] [Article Influence: 27.6] [Reference Citation Analysis]
212 Yang AD, Hewitt DB, Blay E Jr, Kreutzer LJ, Quinn CM, Cradock KA, Prachand V, Bilimoria KY; Illinois Surgical Quality Improvement Collaborative (ISQIC). Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis. Ann Surg 2020;271:1072-9. [PMID: 30632990 DOI: 10.1097/SLA.0000000000003124] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
213 Jung J, Koo IG, Choi MY, Yu Z, Kim M, Collins GJ. An Electrical Thrombectomy Device Using Plasma Created Chemistry in a Saline Environment to Dissolve Vascular Clots: An Electrical Thrombectomy Device Using Plasma Created Chemistry. Plasma Processes Polym 2012;9:463-7. [DOI: 10.1002/ppap.201100142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
214 Gressel GM, Marcus JZ, Mullen MM, Sinno AK. Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice Statement. Gynecol Oncol 2021;160:312-21. [PMID: 33257014 DOI: 10.1016/j.ygyno.2020.11.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
215 Brotman DJ, Jaffer AK. Prevention of venous thromboembolism in the geriatric patient. Cardiol Clin 2008;26:221-34, vi. [PMID: 18406996 DOI: 10.1016/j.ccl.2007.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
216 Samama CM, Lecoules N, Kierzek G, Claessens YE, Riou B, Rosencher N, Mismetti P, Sautet A, Barrellier MT, Apartsin K, Jonas M, Caeiro JR, van der Veen AH, Roy PM; FONDACAST Study Group. Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injury. J Thromb Haemost 2013;11:1833-43. [PMID: 23965181 DOI: 10.1111/jth.12395] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
217 Cunningham RS. Therapeutic Options for the Treatment of Cancer-Associated Thrombosis. Seminars in Oncology Nursing 2005;21:21-40. [DOI: 10.1016/j.soncn.2005.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
218 Clément C, Rossi P, Aissi K, Barthelemy P, Guibert N, Auquier P, Ragni E, Rossi D, Frances Y, Bastide C. Incidence, Risk Profile and Morphological Pattern of Lower Extremity Venous Thromboembolism After Urological Cancer Surgery. Journal of Urology 2011;186:2293-7. [DOI: 10.1016/j.juro.2011.07.074] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
219 Felder S, Rasmussen MS, King R, Sklow B, Kwaan M, Madoff R, Jensen C. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2018;11:CD004318. [PMID: 30481366 DOI: 10.1002/14651858.CD004318.pub3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
220 Strömberg J, Sadr-Azodi O, Videhult P, Hammarqvist F, Sandblom G. Incidence and risk factors for symptomatic venous thromboembolism following cholecystectomy. Langenbecks Arch Surg 2015;400:463-9. [PMID: 25682056 DOI: 10.1007/s00423-015-1284-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
221 Bradley CT, Brasel KJ, Miller JJ, Pappas SG. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol 2010;17:31-9. [PMID: 19707830 DOI: 10.1245/s10434-009-0671-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
222 Qadan M, Tyson M, McCafferty MH, Hohmann SF, Polk HC Jr. Venous thromboembolism in elective operations: balancing the choices. Surgery 2008;144:654-60, discussion 660-1. [PMID: 18847651 DOI: 10.1016/j.surg.2008.06.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
223 Hamada SR, Espina C, Guedj T, Buaron R, Harrois A, Figueiredo S, Duranteau J. High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol. Ann Intensive Care 2017;7:97. [PMID: 28900890 DOI: 10.1186/s13613-017-0315-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
224 Dybdahl D, Walliser G, Pershing M, Collins C, Robinson D. Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients. Clin Med Insights Blood Disord 2019;12:1179545X19863814. [PMID: 31360075 DOI: 10.1177/1179545X19863814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Levin PD, Weissman C. Obesity, metabolic syndrome, and the surgical patient. Anesthesiol Clin 2009;27:705-19. [PMID: 19942175 DOI: 10.1016/j.anclin.2009.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
226 Donnellan E, Kevane B, Bird BR, Ainle FN. Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol 2014;21:134-43. [PMID: 24940094 DOI: 10.3747/co.21.1864] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
227 Steib A, Laporte S, Vailly B, Rohr S, Daudenthun I, Geffroy A, Mazoyer E, Wind P. Chirurgie digestive et varices. Annales Françaises d'Anesthésie et de Réanimation 2005;24:890-901. [DOI: 10.1016/j.annfar.2005.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
228 Nishimori M, Ballantyne JC, Low JH, Nishimori M. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd005059.pub2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
229 Innis WP, Anderson TD. Deep venous thrombosis and pulmonary embolism in otolaryngologic patients. American Journal of Otolaryngology 2009;30:230-3. [DOI: 10.1016/j.amjoto.2008.06.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
230 Hennessey P, Semenov YR, Gourin CG. The effect of deep venous thrombosis on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope 2012;122:2199-204. [PMID: 22865644 DOI: 10.1002/lary.23459] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
231 Wang H, Chen W, Su Y, Li Z, Li M, Wu Z, Zhang Y. Thrombotic risk assessment questionary helps increase the use of thromboprophylaxis for patients with pelvic and acetabular fractures. Indian J Orthop 2012;46:413-9. [PMID: 22912516 DOI: 10.4103/0019-5413.98830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
232 Taguchi K, Shimomura M, Egi H, Hattori M, Mukai S, Kochi M, Sada H, Sumi Y, Nakashima I, Akabane S, Sato K, Ohdan H. Is laparoscopic colorectal surgery with continuation of antiplatelet therapy safe without increasing bleeding complications? Surg Today 2019;49:948-57. [PMID: 31230127 DOI: 10.1007/s00595-019-01839-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
233 Expósito-Ruiz M, Arcelus JI, Caprini JA, López-Espada C, Bura-Riviere A, Amado C, Loring M, Mastroiacovo D, Monreal M; RIETE Investigators. Timing and characteristics of venous thromboembolism after noncancer surgery. J Vasc Surg Venous Lymphat Disord 2021;9:859-867.e2. [PMID: 33248295 DOI: 10.1016/j.jvsv.2020.11.017] [Reference Citation Analysis]
234 Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford). 2012;14:506-513. [PMID: 22762398 DOI: 10.1111/j.1477-2574.2012.00479.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
235 Jabira S, Mitwally H, Saad M, Karic E, Gazwi K, Elzeer H, Elshafei M. Unfractionated heparin as a safe alternative in a case of low molecular weight heparin-induced thrombocytosis: A case report. Ann Med Surg (Lond) 2021;65:102370. [PMID: 34026103 DOI: 10.1016/j.amsu.2021.102370] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Akl EA, Labedi N, Terrenato I, Barba M, Sperati F, Sempos EV, Muti P, Cook D, Schünemann H, Akl EA. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd009447] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
237 Rafii H, Frère C, Benzidia I, Crichi B, Andre T, Assenat E, Bournet B, Carpentier A, Connault J, Doucet L, Durant C, Emmerich J, Gris J, Hij A, Le Hello C, Madelaine I, Messas E, Ndour A, Villiers S, Marjanovic Z, Ait Abdallah N, Yannoutsos A, Farge D. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC). JMV-Journal de Médecine Vasculaire 2020;45:28-40. [DOI: 10.1016/j.jdmv.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Hogan AM, Hoti E, Winter DC, Ridgway PF, Maguire D, Geoghegan JG, Traynor O. Quality of life after iatrogenic bile duct injury: a case control study. Ann Surg 2009;249:292-5. [PMID: 19212184 DOI: 10.1097/SLA.0b013e318195c50c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
239 Mahan C, Holdsworth M, Welch S, Borrego M, Spyropoulos A. Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event. Thromb Haemost 2017;106:405-15. [DOI: 10.1160/th11-02-0132] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 11.8] [Reference Citation Analysis]
240 Cayley WE Jr. Preventing deep vein thrombosis in hospital inpatients. BMJ 2007;335:147-51. [PMID: 17641348 DOI: 10.1136/bmj.39247.542477.AE] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
241 Kucher N, Spirk D, Baumgartner I, Mazzolai L, Korte W, Nobel D, Banyai M, Bounameaux H. Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Ann Oncol 2010;21:931-5. [PMID: 19828560 DOI: 10.1093/annonc/mdp406] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
242 Jung YJ, Seo HS, Park CH, Jeon HM, Kim JI, Yim HW, Song KY. Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial. JAMA Surg 2018;153:939-46. [PMID: 30027281 DOI: 10.1001/jamasurg.2018.2081] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
243 Zurawska U, Parasuraman S, Goldhaber SZ. Prevention of Pulmonary Embolism in General Surgery Patients. Circulation 2007;115. [DOI: 10.1161/circulationaha.106.674663] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
244 Drappatz J, Schiff D, Kesari S, Norden AD, Wen PY. Medical management of brain tumor patients. Neurol Clin 2007;25:1035-71, ix. [PMID: 17964025 DOI: 10.1016/j.ncl.2007.07.015] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
245 Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg 2011;35:881-7. [PMID: 21264469 DOI: 10.1007/s00268-011-0957-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
246 Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan. J Thromb Haemost 2006;4:581-6. [DOI: 10.1111/j.1538-7836.2006.01786.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
247 Lindqvist PG, Torsson J, Almqvist A, Björgell O. Postpartum thromboembolism: severe events might be preventable using a new risk score model. Vasc Health Risk Manag 2008;4:1081-7. [PMID: 19183756 DOI: 10.2147/vhrm.s2831] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
248 Anaya DA, Nathens AB. Thrombosis and Coagulation: Deep Vein Thrombosis and Pulmonary Embolism Prophylaxis. Surgical Clinics of North America 2005;85:1163-77. [DOI: 10.1016/j.suc.2005.10.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
249 Fitzgerald J. Venous thromboembolism: have we made headway? Orthop Nurs 2010;29:226-34; quiz 235-6. [PMID: 20664458 DOI: 10.1097/NOR.0b013e3181e517af] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
250 Minet C, Potton L, Bonadona A, Hamidfar-Roy R, Somohano CA, Lugosi M, Cartier JC, Ferretti G, Schwebel C, Timsit JF. Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis. Crit Care 2015;19:287. [PMID: 26283414 DOI: 10.1186/s13054-015-1003-9] [Cited by in Crossref: 95] [Cited by in F6Publishing: 70] [Article Influence: 15.8] [Reference Citation Analysis]
251 Connolly GC, Francis CW. Cancer-associated thrombosis. Hematology Am Soc Hematol Educ Program 2013;2013:684-91. [PMID: 24319253 DOI: 10.1182/asheducation-2013.1.684] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
252 Hein L, Wille H. Antithrombotika und Antihämorrhagika. In: Schwabe U, Paffrath D, Ludwig W, Klauber J, editors. Arzneiverordnungs-Report 2019. Berlin: Springer Berlin Heidelberg; 2019. pp. 531-55. [DOI: 10.1007/978-3-662-59046-1_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
253 Osborne NH, Wakefield TW, Henke PK. Venous Thromboembolism in Cancer Patients Undergoing Major Surgery. Ann Surg Oncol 2008;15:3567-78. [DOI: 10.1245/s10434-008-0151-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
254 Levine MN, Lee AY, Kakkar AK. From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. J Thromb Haemost 2003;1:1456-63. [DOI: 10.1046/j.1538-7836.2003.00275.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
255 Van PY, Schreiber MA. Contemporary thromboprophylaxis of trauma patients. Curr Opin Crit Care 2016;22:607-12. [PMID: 27749357 DOI: 10.1097/MCC.0000000000000365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
256 Berlot G, Calderan C, Vergolini A, Bianchi M, Viviani M, Bussani R, Torelli L, Lucangelo U. Pulmonary embolism in critically ill patients receiving antithrombotic prophylaxis: a clinical-pathologic study. J Crit Care 2011;26:28-33. [PMID: 20537503 DOI: 10.1016/j.jcrc.2010.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
257 Simonneau G, Laporte S, Mismetti P, Derlon A, Samii K, Samama CM, Bergman JF. A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost. 2006;4:1693-1700. [PMID: 16796710 DOI: 10.1111/j.1538-7836.2006.02083.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
258 Ishida K, Masuda M. Review of Acute Pulmonary Embolism in a General Hospital. Surg Today 2007;37:740-4. [DOI: 10.1007/s00595-006-3496-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
259 Haas S, Hohmann V, Bramlage P. Prevention of Venous Thromboembolism Using Enoxaparin in Day Surgery: Results of the SMART Noninterventional Study. Clin Appl Thromb Hemost 2012;18:265-71. [DOI: 10.1177/1076029611425379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
260 Dotsenko O, Kakkar AK. Thrombosis and cancer. Ann Oncol 2006;17 Suppl 10:x81-4. [PMID: 17018757 DOI: 10.1093/annonc/mdl242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
261 Wickham N, Gallus AS, Walters BN, Wilson A; NHMRC VTE Prevention Guideline Adaptation Committee. Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline. Intern Med J 2012;42:698-708. [PMID: 22697152 DOI: 10.1111/j.1445-5994.2012.02808.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
262 Gao S, Escalante C. Venous thromboembolism and malignancy. Expert Rev Anticancer Ther 2004;4:303-20. [PMID: 15056060 DOI: 10.1586/14737140.4.2.303] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
263 Hardy RG, Williams L, Dixon JM. Use of enoxaparin results in more haemorrhagic complications after breast surgery than unfractionated heparin. British Journal of Surgery 2008;95:834-6. [DOI: 10.1002/bjs.6203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
264 Lee AY. Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res. 2003;110:167-172. [PMID: 14512077 DOI: 10.1016/s0049-3848(03)00347-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
265 Aguayo-albasini JL, Flores-pastor B, Soria-aledo V. Sistema GRADE: clasificación de la calidad de la evidencia y graduación de la fuerza de la recomendación. Cirugía Española 2014;92:82-8. [DOI: 10.1016/j.ciresp.2013.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
266 Decousus H, Rivron-guillot K, Girard G, Moulin N. Clinical efficacy and safety of fondaparinux in the prevention and treatment of venous and arterial thrombosis. Future Cardiology 2005;1:743-58. [DOI: 10.2217/14796678.1.6.743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
267 Matar CF, Kahale LA, Hakoum MB, Tsolakian IG, Etxeandia-Ikobaltzeta I, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA. Anticoagulation for perioperative thromboprophylaxis in people with cancer. Cochrane Database Syst Rev 2018;7:CD009447. [PMID: 29993117 DOI: 10.1002/14651858.CD009447.pub3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
268 Yamashita Y, Bekki Y, Imai D, Ikegami T, Yoshizumi T, Ikeda T, Kawanaka H, Nishie A, Shirabe K, Maehara Y. Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer. Thromb Res. 2014;134:826-831. [PMID: 25156238 DOI: 10.1016/j.thromres.2014.07.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
269 Colwell CW, Lassen MR, Bergqvist D, Geerts WH, Pineo GF, Heit JA, Ray JG. Letters to the Editor. The Journal of Arthroplasty 2006;21:148-9. [DOI: 10.1016/j.arth.2005.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
270 Berges A, Laporte S, Epinat M, Zufferey P, Alamartine E, Tranchand B, Decousus H, Mismetti P; PROPHRE.75 Study Group. Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old. Br J Clin Pharmacol 2007;64:428-38. [PMID: 17509040 DOI: 10.1111/j.1365-2125.2007.02920.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
271 Henke P, Froehlich J, Upchurch G, Wakefield T. The Significant Negative Impact of In-Hospital Venous Thromboembolism after Cardiovascular Procedures. Annals of Vascular Surgery 2007;21:545-50. [DOI: 10.1016/j.avsg.2007.03.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
272 Deng A, Galanis T, Graham MG. Venous Thromboembolism in Cancer Patients. Hospital Practice 2015;42:24-33. [DOI: 10.3810/hp.2014.12.1167] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
273 Al-Hameed F, Al-Dorzi HM, Aboelnazer E. The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital. Thromb J 2014;12:9. [PMID: 24891840 DOI: 10.1186/1477-9560-12-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
274 American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin, Number 232. Obstet Gynecol 2021;138:e1-e15. [PMID: 34259490 DOI: 10.1097/AOG.0000000000004445] [Reference Citation Analysis]
275 Junqueira DR, Perini E, Penholati RR, Carvalho MG, Junqueira DR. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007557.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
276 Leake PA, Urbach DR. Measuring processes of care in general surgery: assessment of technical and nontechnical skills. Surg Innov 2010;17:332-9. [PMID: 20798082 DOI: 10.1177/1553350610379426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
277 Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013;11:56-70. [PMID: 23217107 DOI: 10.1111/jth.12070] [Cited by in Crossref: 366] [Cited by in F6Publishing: 269] [Article Influence: 45.8] [Reference Citation Analysis]
278 Gavriel H, Thompson E, Kleid S, Chan S, Sizeland A. Safety of thromboprophylaxis after oncologic head and neck surgery. Study of 1018 patients. Head Neck 2012. [DOI: 10.1002/hed.23158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
279 Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, Demartines N, Vignaud M, Alvarez A, Singh PM, Lobo DN. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2016;40:2065-2083. [PMID: 26943657 DOI: 10.1007/s00268-016-3492-3] [Cited by in Crossref: 248] [Cited by in F6Publishing: 162] [Article Influence: 62.0] [Reference Citation Analysis]
280 Smart P, Burbury K, Lingaratnam S, Lynch AC, Mackay J, Heriot A. Thromboprophylaxis among Australasian colorectal surgeons: Thromboprophylaxis in colon cancer. ANZ J Surg 2013;83:646-50. [DOI: 10.1111/j.1445-2197.2012.06245.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
281 Kirkpatrick JR, Smith BM, Zapas JL, Thomas WL. Clinical Impact of a Value-Based Decision: A Surgical Case Study. Journal of the American College of Surgeons 2013;216:800-11. [DOI: 10.1016/j.jamcollsurg.2012.12.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
282 Al-Dorzi HM, Cherfan A, Al-Harbi S, Al-Askar A, Al-Azzam S, Hroub A, Olivier J, Al-Hameed F, Al-Moamary M, Abdelaal M, Poff GA, Arabi YM. Knowledge of thromboprophylaxis guidelines pre- and post-didactic lectures during a venous thromboembolism awareness day at a tertiary-care hospital. Ann Thorac Med 2013;8:165-9. [PMID: 23922612 DOI: 10.4103/1817-1737.114298] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
283 Ageno W, Dentali F. Prevention of in-hospital VTE: why can't we do better? The Lancet 2008;371:361-2. [DOI: 10.1016/s0140-6736(08)60177-4] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
284 Yang C, Zhu L. Sudden death caused by acute pulmonary embolism after laparoscopic total extraperitoneal inguinal hernia repair: a case report and literature review. Hernia. 2017;21:481-486. [PMID: 28176033 DOI: 10.1007/s10029-017-1587-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
285 Henke PK, Ferguson E, Varma M, Deatrick KB, Wakefield GTW, Woodrum DT. Proximate versus nonproximate risk factor associated primary deep venous thrombosis: Clinical spectrum and outcomes. Journal of Vascular Surgery 2007;45:998-1007. [DOI: 10.1016/j.jvs.2007.01.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
286 Yhim HY, Jang MJ, Bang SM, Kim KH, Kim YK, Nam SH, Bae SH, Kim SH, Mun YC, Kim I, Jung CW, Oh D. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2014;12:1035-43. [PMID: 24837640 DOI: 10.1111/jth.12611] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
287 Bazzle LJ, Brainard BM. Postoperative Hemostasis Monitoring and Management. Veterinary Clinics of North America: Small Animal Practice 2015;45:995-1011. [DOI: 10.1016/j.cvsm.2015.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
288 Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M. Elevated risk of venous thromboembolic events in patients with inflammatory myopathies. Vasc Health Risk Manag 2016;12:233-8. [PMID: 27350751 DOI: 10.2147/VHRM.S75308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
289 Carrier M, Altman AD, Blais N, Diamantouros A, Mcleod D, Moodley U, Nguyen C, Young S, Schwenter F. Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery. The American Journal of Surgery 2019;218:537-50. [DOI: 10.1016/j.amjsurg.2018.11.046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
290 Turpie AG, Eriksson BI, Bauer KA, Lassen MR. New Pentasaccharides for the Prophylaxis of Venous Thromboembolism. Chest 2003;124:371S-8S. [DOI: 10.1016/s0012-3692(15)31739-6] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
291 Middeldorp S. Heparin: From animal organ extract to designer drug. Thrombosis Research 2008;122:753-62. [DOI: 10.1016/j.thromres.2007.07.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
292 Forrest JB, Camu F, Greer IA, Kehlet H, Abdalla M, Bonnet F, Ebrahim S, Escolar G, Jage J, Pocock S, Velo G, Langman MJ, Bianchi PG, Samama MM, Heitlinger E; POINT Investigators. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth 2002;88:227-33. [PMID: 11883386 DOI: 10.1093/bja/88.2.227] [Cited by in Crossref: 131] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
293 Hunt BJ. The prevention of hospital-acquired venous thromboembolism in the United Kingdom. Br J Haematol 2009;144:642-52. [PMID: 19076173 DOI: 10.1111/j.1365-2141.2008.07517.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
294 Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S; Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA). Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009;119:2920-7. [PMID: 19470892 DOI: 10.1161/CIRCULATIONAHA.108.823211] [Cited by in Crossref: 106] [Cited by in F6Publishing: 16] [Article Influence: 8.8] [Reference Citation Analysis]
295 Bergqvist D, Caprini JA, Dotsenko O, Kakkar AK, Mishra RG, Wakefield TW. Venous Thromboembolism and Cancer. Current Problems in Surgery 2007;44:157-216. [DOI: 10.1067/j.cpsurg.2007.01.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
296 Heerey A, Suri S. Cost effectiveness of dalteparin for preventing venous thromboembolism in abdominal surgery. Pharmacoeconomics 2005;23:927-44. [PMID: 16153135 DOI: 10.2165/00019053-200523090-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
297 Spyropoulos AC, Merli G. Management of venous thromboembolism in the elderly. Drugs Aging 2006;23:651-71. [PMID: 16964988 DOI: 10.2165/00002512-200623080-00003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
298 Fuentes HE, Tafur AJ, Caprini JA. Cancer-associated thrombosis. Disease-a-Month 2016;62:121-58. [DOI: 10.1016/j.disamonth.2016.03.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 6.4] [Reference Citation Analysis]
299 Smetana GW, Cohn SL, Mercado DL, Jaffer AK. Update in perioperative medicine. J Gen Intern Med 2006;21:1329-37. [PMID: 17105527 DOI: 10.1111/j.1525-1497.2006.00630.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
300 Spadarella G, Di Minno A, Donati MB, Mormile M, Ventre I, Di Minno G. From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation. Blood Reviews 2020;39:100613. [DOI: 10.1016/j.blre.2019.100613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
301 Hakeam HA, Al Duhailib Z, Alsemari M, Alwaibah RM, Al Shannan MF, Shalhoub M. Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study. Clin Appl Thromb Hemost 2020;26:1076029620931194. [PMID: 32559127 DOI: 10.1177/1076029620931194] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Turpie A. The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery. International Journal of Clinical Practice 2004;58:483-93. [DOI: 10.1111/j.1368-5031.2004.00183.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
303 Segers AEM, Prins MH, Lensing AWA, Buller HR. Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies? J Thromb Haemost 2005;3:1099-102. [DOI: 10.1111/j.1538-7836.2005.01317.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
304 Gould MK, Jones JP. Thromboprophylaxis in the real world: strengths and limitations of comparative effectiveness research. Chest 2011;140:1401-4. [PMID: 22147816 DOI: 10.1378/chest.11-2576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
305 Bruna Esteban M, Vorwald P, Ortega Lucea S, Ramírez Rodríguez JM; Grupo de Trabajo de Cirugía Esofagogástrica del Grupo Español de Rehabilitación Multimodal (GERM). Enhanced recovery after surgery in gastric resections. Cir Esp 2017;95:73-82. [PMID: 28185641 DOI: 10.1016/j.ciresp.2016.10.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
306 Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Trials*. Critical Care Medicine 2013;41:2088-98. [DOI: 10.1097/ccm.0b013e31828cf104] [Cited by in Crossref: 92] [Cited by in F6Publishing: 36] [Article Influence: 11.5] [Reference Citation Analysis]
307 Kanchanabat B, Stapanavatr W, Manusirivithaya S, Srimantayamas S. The rate and mortality of postoperative venous thromboembolism of moderate risk surgery in Asian patients without thrombo-prophylaxis: systematic review with meta-analysis. World J Surg 2014;38:194-202. [PMID: 24101013 DOI: 10.1007/s00268-013-2222-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
308 Gutt CN, Oniu T, Wolkener F, Mehrabi A, Mistry S, Büchler MW. Prophylaxis and treatment of deep vein thrombosis in general surgery. The American Journal of Surgery 2005;189:14-22. [DOI: 10.1016/j.amjsurg.2004.04.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
309 Prandoni P. Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines. Thromb J 2008;6:13. [PMID: 18782432 DOI: 10.1186/1477-9560-6-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
310 Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, Johnston FM, Kheng M, Hirose K, Wolfgang CL, Haut E, Pawlik TM. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg 2014;18:1116-24. [PMID: 24337986 DOI: 10.1007/s11605-013-2432-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
311 Planès A. Review of bemiparin sodium--a new second-generation low molecular weight heparin and its applications in venous thromboembolism. Expert Opin Pharmacother 2003;4:1551-61. [PMID: 12943485 DOI: 10.1517/14656566.4.9.1551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
312 Khorana AA, Rubens D, Francis CW. Screening high-risk cancer patients for VTE: A prospective observational study. Thrombosis Research 2014;134:1205-7. [DOI: 10.1016/j.thromres.2014.09.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
313 Weiss MJ, Kim Y, Ejaz A, Spolverato G, Haut ER, Hirose K, Wolfgang CL, Choti MA, Pawlik TM. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford) 2014;16:892-8. [PMID: 24888461 DOI: 10.1111/hpb.12278] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
314 Shalhoub J, Lawton R, Hudson J, Baker C, Bradbury A, Dhillon K, Everington T, Gohel MS, Hamady Z, Hunt BJ, Stansby G, Warwick D, Norrie J, Davies AH; GAPS trial investigators. Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study): randomised controlled trial. BMJ 2020;369:m1309. [PMID: 32404430 DOI: 10.1136/bmj.m1309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
315 Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points. Chest 2004;126:501-8. [DOI: 10.1378/chest.126.2.501] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
316 Fitzmaurice DA, Murray E. Thromboprophylaxis for adults in hospital. BMJ 2007;334:1017-8. [PMID: 17510109 DOI: 10.1136/bmj.39210.496505.BE] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
317 Tardy B, Picard S, Guirimand F, Chapelle C, Danel Delerue M, Celarier T, Ciais JF, Vassal P, Salas S, Filbet M, Gomas JM, Guillot A, Gaultier JB, Merah A, Richard A, Laporte S, Bertoletti L. Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study. J Thromb Haemost 2017;15:420-8. [PMID: 28035750 DOI: 10.1111/jth.13606] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
318 Mahan CE, Holdsworth MT, Welch SM, Borrego M, Spyropoulos AC. Long-term attack rates, as compared with incidence rates, may provide improved cost-estimates in venous thromboembolism. A reply to S. D. Grosse. Thromb Haemost 2017;107:194-5. [DOI: 10.1160/th11-11-0802] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
319 Pannucci CJ, Dreszer G, Wachtman CF, Bailey SH, Portschy PR, Hamill JB, Hume KM, Hoxworth RE, Rubin JP, Kalliainen LK, Pusic AL, Wilkins EG. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg 2011;128:1093-103. [PMID: 22030491 DOI: 10.1097/PRS.0b013e31822b6817] [Cited by in Crossref: 114] [Cited by in F6Publishing: 15] [Article Influence: 11.4] [Reference Citation Analysis]
320 Yeo DX, Junnarkar S, Balasubramaniam S, Tan YP, Low JK, Woon W, Pang TC. Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients: a systematic review. World J Surg. 2015;39:150-157. [PMID: 25189450 DOI: 10.1007/s00268-014-2763-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
321 Alban S. Adverse effects of heparin. Handb Exp Pharmacol 2012;:211-63. [PMID: 22566227 DOI: 10.1007/978-3-642-23056-1_10] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
322 Eikelboom JW, Hirsh J. Deep Vein Thrombosis Prophylaxis: Response. Chest 2009;136:1700-1. [DOI: 10.1378/chest.09-1970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
323 Chen CM, Disa JJ, Cordeiro PG, Pusic AL, Mccarthy CM, Mehrara BJ. The Incidence of Venous Thromboembolism After Oncologic Head and Neck Reconstruction. Annals of Plastic Surgery 2008;60:476-9. [DOI: 10.1097/sap.0b013e31816fd7e7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
324 Reinke CE, Drebin JA, Kreider S, Kean C, Resnick A, Raper S, Kelz RR. Timing of preoperative pharmacoprophylaxis for pancreatic surgery patients: a venous thromboembolism reduction initiative. Ann Surg Oncol 2012;19:19-25. [PMID: 21725687 DOI: 10.1245/s10434-011-1858-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
325 Falanga A, Vignoli A, Diani E, Marchetti M. Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival. Patient Relat Outcome Meas 2011;2:175-88. [PMID: 22915978 DOI: 10.2147/PROM.S10099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
326 Russell MC. Complications following hepatectomy. Surg Oncol Clin N Am. 2015;24:73-96. [PMID: 25444470 DOI: 10.1016/j.soc.2014.09.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
327 Lee AY. Dalteparin sodium in the management of thromboembolic disorders. Therapy 2006;3:461-73. [DOI: 10.2217/14750708.3.4.461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
328 Birth M, Figueras J, Bernardini S, Troen T, Günther K, Mirza D, Mortensen FV. Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study. Patient Saf Surg 2009;3:13. [PMID: 19545437 DOI: 10.1186/1754-9493-3-13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
329 Bergqvist D. Low-molecular-weight heparin for the prevention of postoperative venous thromboembolism after abdominal surgery: a review: . Current Opinion in Pulmonary Medicine 2005;11:392-7. [DOI: 10.1097/01.mcp.0000174233.55348.16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
330 Shestak KC, Rios L, Pollock TA, Aly A. Evidenced-Based Approach to Abdominoplasty Update. Aesthet Surg J 2019;39:628-42. [PMID: 30481261 DOI: 10.1093/asj/sjy215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]